-The Hindu Lender sees ‘considerable downside risk’ from latest COVID wave, says may revise forecast in July The Asian Development Bank has raised its forecast for india’s growth in 2021-22 to 11%, from 8% earlier, even as it warned that failure to control the resurgence of COVID-19 cases including April’s exponential jump poses a “considerable downside risk to the recovery”. ‘Targeted containment’ In its assessment based on end-March data, the ADB cited this year’s...

-The Telegraph Centre’s revised policy has more than doubled the population of potential beneficiaries without immediate provisions for the extra doses needed india is likely to face extreme shortages of Covid-19 vaccines if all adults eligible for vaccination begin queuing up for the jabs from May 1, health and industry experts have said. The Centre’s revised vaccination policy has more than doubled the population of potential vaccine beneficiaries without immediate provisions for the...

-The indian Express As many as 16 private hospitals in Patna have oxygen stock of less than one to two days, it is learnt. Among these are Park Surgicals, Royal Hospital, Samay Hospital, Siddharth Hospital, Capital Hospital, Himalaya Hospital, Nidan Hospital and Tara Hospital. Patna: * On Sunday, four Covid-19 patients died at a hospital in Kankerbagh, Patna, allegedly due to shortage of oxygen. * A day before that, a 36-year-old person died...

-The indian Express The pandemic has forced us to rethink how we live our lives. We must also allow it to dismantle our exam-centric education system that only creates hyper-competitiveness and perpetuates inequalities. With the aggressive return of COVID-19, we are experiencing heightened anxiety. And amid this turmoil, we are also witnessing the breakdown of “normalcy” in our education system. As board exams get cancelled or postponed around the country, students, parents...

-The Hindu Over the last few decades, intellectual property rules have served as a lethal barrier to the right to access healthcare Even an unprecedented pandemic can do little, it appears, to upset the existing global regime governing monopoly rights over the production and distribution of life-saving drugs. If anything, since the onset of COVID-19, we’ve only seen a reaffirmation of intellectual property rules that have served as a lethal barrier to...